Pfizer, Samsung Biologics build on biosimilar deals now worth $897M - endpts.com/pfizer-samsung…

Sanofi inks deal to help Saudi Arabia manufacture vaccines locally - endpts.com/sanofi-inks-de…

Teva reportedly considering sale of API unit - endpts.com/teva-reportedl…

Q&A: Fujifilm Diosynth’s new CEO Lars Petersen talks priorities and plans for the CDMO - endpts.com/qa-fujifilm-di…

Manufacturing roundup: GenScript to boost production capacity; SK Biosciences inks MOU for its vaccine in Thailand - endpts.com/manufacturing-…

Thermo Fisher to acquire data intelligence company CorEvitas for $900M+ - endpts.com/thermo-fisher-…

We've got some exciting news here at Endpoints News. The one and only Lia DeGroot is joining us to help cover the FDA! She'll be teaming up with Zach Brennan to keep our readers updated on the regulatory and legislative world, part of our push to expand our DC presence.

Updated: FDA to import more of common cancer drug from China after Indian site closure - endpts.com/fda-to-import-…

Our #WIB23 event is tomorrow! Join us for a celebration of our 20 honorees, plus panels with AbbVie's Azurii Collier, Iolyx Therapeutics' Elizabeth Jeffords, Ventyx, ADARx, and ImmPACT's Sheila Gujrathi and NIBR's Fiona Marshall, hosted by Amber Tong and me. womeninbio23.endpts.com

WHO sounds the alarm over more contaminated cough syrup in Africa - endpts.com/who-sounds-the…

Tornado severely damages Pfizer's large sterile injectable plant in North Carolina - endpts.com/tornado-severe…

All of us at Pfizer have spent the past 24 hours concerned about our colleagues and contractors at our Rocky Mount facility, which sustained a tremendous amount of damage yesterday when a tornado touched down in the community. I am very relieved to share that all have been

📰We've got some BIG news here at Endpoints today! We're expanding our newsroom to the UK 🇬🇧, opening up new coverage in health tech 👩‍💻, and adding a strategic leader for our events business 🏟️. endpts.com/expanding-the-…

The Endpoints Slack interview: Lux's Josh Wolfe on AI hype, biotech markets, Twitter and more - endpts.com/the-endpoints-…

Exclusive: Kincell Bio launches with a $36M Series A, valuing the CDMO cell therapy startup at $66M I talked with CEO Bruce Thompson about his plans for Kincell, including looking for the right, measured M&A deals to expand: endpts.com/exclusive-cell…

Akorn Pharmaceuticals' bankruptcy, recalls cause lead poisoning drug shortage - endpts.com/akorn-pharmace…

This is going to be a fun evening -- I hope you can join Endpoints News in Boston next month! 🤵 Andrew Dunn Ryan Cross the Science Boss Kyle LaHucik + John Carroll have been working through the list of exciting startups ... we can't wait to share them w/ you eleven23.endpts.com/?utm_medium=or…

Regeneron plans for quick redecision on CRL for higher dose of Eylea - endpts.com/regeneron-plan…

Emergent lays off 400 workers, pulls back from focus on CDMO operations - endpts.com/emergent-lays-…

Novo Nordisk sees 'uncertainty' in Wegovy supply in the coming months as it provides insight on manufacturing plans - endpts.com/novo-nordisk-s…